ES2608855T3 - Recubrimiento de endoprótesis cubriendo la totalidad de la superficie - Google Patents
Recubrimiento de endoprótesis cubriendo la totalidad de la superficie Download PDFInfo
- Publication number
- ES2608855T3 ES2608855T3 ES06742306.1T ES06742306T ES2608855T3 ES 2608855 T3 ES2608855 T3 ES 2608855T3 ES 06742306 T ES06742306 T ES 06742306T ES 2608855 T3 ES2608855 T3 ES 2608855T3
- Authority
- ES
- Spain
- Prior art keywords
- entire surface
- coating covering
- acid
- stent coating
- reticulated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Wood Science & Technology (AREA)
- Materials Engineering (AREA)
- Plant Pathology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para el recubrimiento cubriendo la totalidad de la superficie de endoprótesis rejadas o reticuladas, en donde en un primer paso de recubrimiento, se revisten por un recubrimiento polímero sea completamente sea parcialmente los puntales de la endoprótesis formando la estructura rejada o reticulada y en un segundo paso de recubrimiento, se recubre por un recubrimiento polímero cubriendo la totalidad de la superficie por lo menos una parte de los intersticios entre los puntales formando la estructura rejada o reticulada.
Description
5
15
25
35
45
55
65
celecoxib, la talidomida, el fasudil®, la ciclosporina, el inhibidor 2ɯ de la proliferación de CML, epotilona A y B, la mitoxantrona, la azatioprina, el mofetil micofenolato, el antisentido de c myc, el antisentido de b myc, el ácido betulínico, la camptotecina, el PI-88 (oligosacárido sulfatado), la hormona melanocito estimulante (α-MSH), la proteina C activada, el inhibidor de IL1-β, la timosina α-1, el ácido fumárico y sus ésteres, el calcipotriol, el tacalcitol, el lapachol, la β-lapachona, la podofilotoxina, la betulina, ácido podofílinico 2-etilhidrazida, el molgramostim (rhuGM-CSF), el peginterferón α-2b, el lenograstim (r-HuG-CSF), el filgrastim, el macrogol, la dacarbazina, el basiliximab, el daclizumab, la selectina (antagonista de citoquinas), el inhibidor de CETP, la cadherina, inhibidores de citoquinina, el inhibidor de la COX-2, el NFkB, la angiopeptina, la ciprofloxacina, la fluroblastina, anticuerpos monoclonales que inhiben la proliferación de celúlas musculares, antagonistas de bFGF, el probucol, prostaglandinas, 1,11dimetoxicantin-6-ona, la 1-hidroxi-11-metoxicantin-6-ona, la escopoletina, la colchicina, donadores de NO como el tetranitrato de pentaeritritol y sidnoniminas, S-nitrosoderivados, el tamoxifen, la estaurosporina, el β-estradiol, el αestradiol, el estriol, la estrona, el etinilestradiol, el fosfestrol, la medroxiprogesterona, cipionatos de estradiol, benzoatos de estradiol, el tranilast, el kamebakaurin u otros terpenoides que se emplean en la terapia del cáncer, el verapamil, inhibidores de la tirosina quinasa (tirfostinas), la ciclosporina A, el paclitaxel y sus derivados como el 6-αhidroxi-paclitaxel, la baccatina, taxoteros, olígomeros macrociclícos del subóxido de carbono (MCS) y sus derivados preparados sintéticamente u obtenidos de fuentes nativas, la mofebutazona, la acemetacina, el diclofenaco, el lonazolaco, la dapsona, el ácido o-carbamoilfenoxiacético, la lidocaina, el ketoprofeno, el ácido mefenámico, el piroxicam, el meloxicam, el fosfato de cloroquina, la penicilamina, la tumstatina, la avastina, D-24851, SC-58125, la hidroxicloroquina, la auranofina, el aurotiomalato de sodio, el oxaceprol, la β-sitosterina, la ademetionina, la mirtecaina, el polidocanol, la nonivamida, el levomentol, la benzocaina, la aescina, la elipticina, D-24851 (Calbiochem), el colcemid, citocalasina A -E, indanocines, nocadazoles, la proteina S 100, la bacitracina, antagonistas del receptor de vitronectina, la azelastina, el estimulante de la guanidil ciclasa, el inhibidor tisular de la metaloproteinasa 1 y 2, ácidos nucleicos libres, ácidos nucleicos que están incorporados en vehículos virales, fragmentos del ADN y ARN, el inhibidor 1 del activador de plasminógeno, el inhibidor 2 del activador de plasminógeno, oligonucléotidos antisentido, inhibidores de VEGF, el IGF-1, agentes activos del grupo de los antibióticos como el cefadroxil, la cefazolina, el cefaclor, la cefoxitina, la tobramicina, la gentamicina, penicilinas como la dicloxacilina, la oxacilina, sulfonamidas, el metronidazol, antitrombóticos como el argatroban, la aspirina, el abciximab, la antitrombina sintética, la bivalirudina, la coumadina, la enoxaparina, la heparina desulfatada y Nreacetilada, el activador de tejido plasminógeno, el receptor de la membrana plaquetaria GpIIb/IIIa, anticuerpos del inhibidor del factor Xa, inhibidores de la interleucina, la heparina, la hirudina, la r-hirudina, PPACK, la protamina, el sal sódico del ácido 2-metiltiazolidina-2,4-dicarboxílico, la prouroquinasa, la estreptoquinasa, la warfarina, la uroquinasa, vasodilatadores como el dipiramidol, el trapidil, nitroprusidas, antagonistas del PDGF como la triazolopirimidina y la seramina, inhibidores ACE como el captopril, el cilazapril, el lisinopril, el enalapril, el losartan, inhibidores de la tioproteasa, la prostaciclina, el vapiprost, los interferones αβy ϒ, antagonistas de la histamina, bloqueadores de la serotonina, inhibidores de la apoptosis, reguladores de la apoptosis como el p65, el NF-kB o el Bcl-xL, oligonucléotidos antisentido, la halofuginona, la nifedipina, el tocoferol, las vitaminas B1, B2, B6 y B12, el ácido fólico, la molsidomina, polifenoles del té, el galato de epicatequina, el galato de epigalocatequina, ácidos boswélicos y sus derivados, la leflunomida, la anakinra, el etanercept, la sulfasalazina, la dicloxacilina, la tetraciclina, la triamcinolona, la mutamicina, la procainimida, D24851, SC-58125, el ácido retinoico, la quinidina, la disopiramida, la flecainida, la propafenona, el sotalol, la amidorona, esteroides naturales y preparados sintéticamente como la briofilina A, el inotodiol, la maquirosida A, la ghalaquinocida, la mansonina, el streblosid, la hidrocortisona, la betametasona, la dexametasona, sustancias no esteroidales (NSAIDS) como el fenoprofen, el ibuprofen, la indometacina, el naproxen, la fenilbutazona y otros agentes antivirales como el aciclovir, el ganciclovir y la zidovudina, antimicóticos como el cotrimazol, la flucitosina, la griseofulvina, el ketoconazol, el miconazol, la nistatina, la terbinafina, agentes antiprotozoarios como la cloroquina, la mefloquina, la quinina, además terpenoides naturales como la hippocaesculina, el barringtogenol-C21-angelato, la 14-dehidroagrostistaquina, la agrosquerina, la agrostistaquina, la 17-dehidroagrostistaquina, ovatodiolides, el ácido 4,7-oxicicloanisomélico, baccharinoides B1, B2, B3 y B7, la tubeimosida, bruceanoles A, B y C, la bruceantinosida C, yadanziosida N y P, la isodesoxielefantopina, tomenfantopina A y B, coronarina A, B, C y D, el ácido ursolólico, el ácido hiptático A, la zeorina, el iso-iridogermanal, el maitenfoliol, la effusantina A, excisanin A y B, el longuikaurin B, la sculponeatina C, el kamebaunin, leukamenin A y B, la 13,18-dehidro-6-alfa-senecioiloxichaparrina, taxamairina A y B, el regenilol, el triptolido, además la cimarina, la apocimarina, el ácido aristoloquico, la aminopterina, la hidroxiaminopterina, la anemonina, la protoanemonina, la berberina, el cloruro de queliburina, la cicutoxina, la sinococulina, combrestatina A y B, la cudraisoflavona A, la curcumina, la dihidronitidina, el cloruro de nitidina, la 12-beta-hidroxipregnadien-3,20-diona, el bilobol, el ginkgol, el ácido ginkgólico, la helenalina, la indicina, el indicinaN-óxido, la lasiocarpina, el glicósido 1α, justicidina A y B, la larreatina, la maloterina, el malotocromanol, el isobutirilmalotocromanol, la maquirosida A, la marcantina A, la maitansina, la licoridicina, la margetina, la pancratistatina, la liriodenina, el oxoushinsunin, el aristolactam AII, la bispartenolidina, la periplocosida A, la desoxipsorospermina, la psicorubina, la ricina A, la sanguinarina, el ácido de trigo de manwu, la metilsorbifolina, cromonas de spathelia, el stizophyllin, la akagerina, la dihidrousambarensina, la hidroxiusambarina, la estricnopentamina, la estricnofilina, la usambarina, la usambarensina, la dafnoretina, el lariciresinol, el metetoxilariciresinol, el siringaresinol, la umbeliferona, el afromoson, la acetil vismiona B, la desacetil vismiona A, vismiona A y B y áminoacidos que contienen azufre como la cistina así como sales, hidratos, solvatos, enantiomeros, racematos, mezclas de enantiomeros, mezclas de diastereomeros y mezclas de los agentes activos mencionados arriba.
11
Claims (1)
-
imagen1 imagen2 imagen3
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005021622 | 2005-05-05 | ||
DE102005021622.6A DE102005021622B4 (de) | 2005-05-05 | 2005-05-05 | Ganzflächige Beschichtung von Stents |
US68734005P | 2005-06-06 | 2005-06-06 | |
US687340P | 2005-06-06 | ||
PCT/DE2006/000766 WO2006116989A2 (de) | 2005-05-05 | 2006-05-03 | Vollflächige beschichtung von gefässstützen |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2608855T3 true ES2608855T3 (es) | 2017-04-17 |
Family
ID=37295269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES06742306.1T Active ES2608855T3 (es) | 2005-05-05 | 2006-05-03 | Recubrimiento de endoprótesis cubriendo la totalidad de la superficie |
Country Status (17)
Country | Link |
---|---|
US (1) | US8916227B2 (es) |
EP (1) | EP1881853B1 (es) |
JP (1) | JP4758474B2 (es) |
KR (2) | KR20080008364A (es) |
CN (1) | CN101171042B (es) |
AU (1) | AU2006243553B2 (es) |
BR (1) | BRPI0610479B1 (es) |
CA (1) | CA2607413C (es) |
DE (1) | DE102005021622B4 (es) |
ES (1) | ES2608855T3 (es) |
HK (1) | HK1119092A1 (es) |
IL (1) | IL186917A (es) |
MX (1) | MX2007013740A (es) |
PL (1) | PL1881853T3 (es) |
RU (1) | RU2458708C2 (es) |
WO (1) | WO2006116989A2 (es) |
ZA (1) | ZA200709295B (es) |
Families Citing this family (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306166B1 (en) * | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
US10029034B2 (en) * | 2005-12-15 | 2018-07-24 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Drug-eluting articles with improved drug release profiles |
US20070142905A1 (en) * | 2005-12-16 | 2007-06-21 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US7794495B2 (en) * | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
DE102006038239A1 (de) * | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Wirkstoffbeschichtete medizinische Implantate |
DE102006048650A1 (de) * | 2006-10-14 | 2008-04-17 | Dot Gmbh | Funktionelle Beschichtung von Implantaten |
EP2101834B1 (en) | 2006-12-01 | 2015-03-25 | Wake Forest University Health Sciences | Medical devices incorporating collagen inhibitors |
RU2447901C2 (ru) | 2007-01-21 | 2012-04-20 | Хемотек Аг | Медицинский продукт для лечения обтураций просветов организма и для предупреждения угрожающих повторных обтураций |
DE102007034350A1 (de) * | 2007-07-24 | 2009-01-29 | Hemoteq Ag | Biologisch abbaubare Gefäßstütze |
DE102007004589A1 (de) * | 2007-01-30 | 2008-07-31 | Orlowski, Michael, Dr. | Bioresorbierbarer Metallstent mit kontrollierter Resorption |
RU2452517C2 (ru) * | 2007-01-30 | 2012-06-10 | Хемотек Аг | Биоразрушаемое средство для поддержания просвета сосудов |
US20100070020A1 (en) | 2008-06-11 | 2010-03-18 | Nanovasc, Inc. | Implantable Medical Device |
DE102007030438A1 (de) * | 2007-06-29 | 2009-01-08 | Biotronik Vi Patent Ag | Implantat aus einer biokorrodierbaren Magnesiumlegierung und mit einer Beschichtung aus einem Poly(orthoester) |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
DE102007034363A1 (de) * | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Endoprothese |
DE102007034364A1 (de) * | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Degradierbarer Metallstent mit wirkstoffhaltiger Beschichtung |
DE102007038799A1 (de) * | 2007-08-17 | 2009-02-19 | Biotronik Vi Patent Ag | Implantat aus einer biokorrodierbaren Magnesiumlegierung und mit einer Beschichtung aus einem biokorrodierbaren Polyphosphazen |
DE102007050668A1 (de) * | 2007-10-24 | 2009-04-30 | Biotronik Vi Patent Ag | Stent mit einem Grundkörper aus einem bioinerten metallischen Implantatwerkstoff |
DE102007059755A1 (de) * | 2007-12-10 | 2009-06-18 | Biotronik Vi Patent Ag | Implantate mit membrandiffusionskontrollierter Wirkstofffreisetzung |
DE102008037204B4 (de) * | 2008-08-11 | 2016-01-07 | Alfred Buck | Platte zur Fixierung von Knochenfragmenten sowie Verfahren zu deren Herstellung |
EP2349363B1 (en) | 2008-10-09 | 2018-12-05 | MiMedx Group, Inc. | Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches |
ES2773766T3 (es) | 2008-12-19 | 2020-07-14 | Baxalta GmbH | Inhibidores de TFPI y métodos de uso |
US20100161039A1 (en) * | 2008-12-23 | 2010-06-24 | Vipul Dave | Adhesion promoting temporary mask for coated surfaces |
US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
CN104178926B (zh) | 2009-01-16 | 2018-02-09 | Zeus工业品公司 | 利用高粘度材料对ptfe进行电纺丝 |
DE102009005792B4 (de) * | 2009-01-22 | 2019-06-19 | Feg Textiltechnik Forschungs- Und Entwicklungsgesellschaft Mbh | Medizinisches Implantat mit Oberflächenbeschichtung |
DE102009018537A1 (de) | 2009-04-24 | 2010-10-28 | Siegel, Rolf, Dr. Med. | Verwendung von mit Chinazolinon-Derivat oberflächen-modifizierten Silikonformkörpern |
DE102009032119A1 (de) * | 2009-06-26 | 2010-12-30 | Koslar, Björn H. | Gefäßprothese |
EP3064230B1 (en) | 2009-07-10 | 2019-04-10 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
WO2011008393A2 (en) | 2009-07-17 | 2011-01-20 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
DE102009037134A1 (de) * | 2009-07-31 | 2011-02-03 | Aesculap Ag | Tubuläres Implantat zum Ersatz von natürlichen Blutgefäßen |
CN102470030A (zh) | 2009-08-07 | 2012-05-23 | 宙斯工业产品股份有限公司 | 包含静电纺纤维层的假体装置及其制备方法 |
US8808724B2 (en) * | 2009-10-28 | 2014-08-19 | Ethicon, Inc. | Antimicrobial coatings with preferred microstructure for medical devices |
KR101458485B1 (ko) * | 2009-12-24 | 2014-11-07 | 도레이 카부시키가이샤 | 항혈액응고 작용을 갖는 친수성 고분자화합물 |
AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
BR112012030021A2 (pt) * | 2010-05-27 | 2016-08-02 | Hemoteq Ag | revestimento de endropróteses com um revestimento consistindo em uma malha apertada de fibras de polímero |
US9211175B2 (en) | 2010-07-08 | 2015-12-15 | Covidien Lp | Self-detachable medical devices |
FR2962646B1 (fr) | 2010-07-16 | 2012-06-22 | Sofradim Production | Prothese avec element radio-opaque |
US8889211B2 (en) | 2010-09-02 | 2014-11-18 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
US9572907B2 (en) | 2010-10-01 | 2017-02-21 | Covidien Lp | Implantable polymeric films |
CN102782196A (zh) | 2010-10-14 | 2012-11-14 | 宙斯工业产品股份有限公司 | 抗微生物基材 |
US8920867B2 (en) | 2010-10-19 | 2014-12-30 | Covidien Lp | Methods of forming self-supporting films for delivery of therapeutic agents |
US9861590B2 (en) | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
US8632839B2 (en) | 2010-10-19 | 2014-01-21 | Covidien Lp | Methods of forming self-supporting films for delivery of therapeutic agents |
US9144634B2 (en) | 2011-01-14 | 2015-09-29 | Covidien Lp | Medical device with intrapore films |
CN103561682A (zh) | 2011-01-28 | 2014-02-05 | 梅瑞特医药体系股份有限公司 | 静电纺丝ptfe涂层支架及其使用方法 |
DE102011014386A1 (de) * | 2011-03-11 | 2012-09-13 | Hemoteq Ag | Endoprothese mit einer Wirkstoffbeschichtung |
AU2012230966B2 (en) | 2011-03-22 | 2017-05-11 | Applied Medical Resources Corporation | Method of making medical tubing having drainage holes |
KR101064214B1 (ko) * | 2011-04-08 | 2011-09-14 | 강원대학교산학협력단 | 키토산 코팅층을 구비한 약물 용출형 스텐트 및 그 제조방법 |
AU2012253737B2 (en) * | 2011-05-06 | 2015-04-30 | W. L. Gore & Associates, Inc. | Device with echogenic coating |
FR2977790B1 (fr) | 2011-07-13 | 2013-07-19 | Sofradim Production | Prothese pour hernie ombilicale |
US8579924B2 (en) | 2011-07-26 | 2013-11-12 | Covidien Lp | Implantable devices including a mesh and a pivotable film |
GB201113506D0 (en) * | 2011-08-05 | 2011-09-21 | Materialise Nv | Impregnated lattice structure |
US8669360B2 (en) | 2011-08-05 | 2014-03-11 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
US9782957B2 (en) | 2011-08-24 | 2017-10-10 | Covidien Lp | Medical device films |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
US9005308B2 (en) | 2011-10-25 | 2015-04-14 | Covidien Lp | Implantable film/mesh composite for passage of tissue therebetween |
US9179994B2 (en) | 2011-10-25 | 2015-11-10 | Covidien Lp | Implantable film/mesh composite |
US8932621B2 (en) | 2011-10-25 | 2015-01-13 | Covidien Lp | Implantable film/mesh composite |
DE102011117526B4 (de) * | 2011-11-03 | 2015-07-30 | Heraeus Medical Gmbh | Beschichtungsverfahren und Beschichtungsvorrichtung für medizinische Implantate |
US10239262B2 (en) * | 2011-11-21 | 2019-03-26 | Nanofiber Solutions, Llc | Fiber scaffolds for use in tracheal prostheses |
WO2013090878A1 (en) * | 2011-12-15 | 2013-06-20 | Vascudyne, Llc | Coronary artery bypass grafts and vascular conduites |
CN110064076A (zh) | 2012-01-16 | 2019-07-30 | 麦瑞通医疗设备有限公司 | 被旋转纺丝材料覆盖的医疗器械和制造方法 |
US20130231753A1 (en) * | 2012-03-02 | 2013-09-05 | Cook Medical Technologies Llc | Endoluminal prosthesis having anti-migration coating |
CA2867363C (en) | 2012-03-21 | 2023-02-28 | Baxter International Inc. | Tfpi inhibitors and methods of use |
US10206769B2 (en) | 2012-03-30 | 2019-02-19 | Covidien Lp | Implantable devices including a film providing folding characteristics |
FR2992662B1 (fr) | 2012-06-28 | 2014-08-08 | Sofradim Production | Tricot avec picots |
FR2992547B1 (fr) | 2012-06-29 | 2015-04-24 | Sofradim Production | Prothese pour hernie |
KR101202546B1 (ko) * | 2012-08-27 | 2012-11-19 | 강대현 | 이벤트 화염 분사 장치 |
US11541154B2 (en) | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
US9198999B2 (en) | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
RU2015113943A (ru) * | 2013-01-14 | 2017-02-16 | Николай Свиридович Гаврюшенко | Способ профилактики и/или лечения поражений суставов (варианты) |
CN104884694B (zh) | 2013-03-13 | 2018-09-11 | 麦瑞通医疗设备有限公司 | 连续沉积的纤维材料以及相关联的装置和方法 |
WO2014159399A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
US20150011492A1 (en) * | 2013-07-02 | 2015-01-08 | Wisconsin Alumni Research Foundation | Anti-restenosis compositions and methods |
WO2015153220A1 (en) | 2014-04-02 | 2015-10-08 | Boston Scientific Scimed, Inc. | Covered endoscopic stents with adhesion elements |
RU2568917C1 (ru) * | 2014-04-17 | 2015-11-20 | Государственное автономное учреждение здравоохранения "Республиканская клиническая больница Министерства здравоохранения Республики Татарстан" | Способ изготовления спейсера из костного цемента |
US11241520B2 (en) | 2014-08-07 | 2022-02-08 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US9655998B2 (en) | 2014-08-07 | 2017-05-23 | Cook Medical Technologies Llc | Encapsulated drug compositions and methods of use thereof |
US9180226B1 (en) | 2014-08-07 | 2015-11-10 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US10195061B2 (en) | 2014-10-22 | 2019-02-05 | Boston Scientific Scimed, Inc. | Controlled tissue ingrowth stent covering |
CN105796207B (zh) * | 2014-12-30 | 2018-05-11 | 先健科技(深圳)有限公司 | 滤器及其制作方法 |
WO2016138221A1 (en) | 2015-02-26 | 2016-09-01 | Merit Medical Systems, Inc. | Layered medical appliances and methods |
CN104874017B (zh) * | 2015-05-13 | 2017-09-19 | 中国人民解放军总医院 | 复合Tβ4的胶原‑壳聚糖组织工程支架及其制备方法和应用 |
CN106267356B (zh) * | 2015-05-22 | 2020-01-03 | 先健科技(深圳)有限公司 | 植入医疗器械预制件、植入医疗器械及其制备方法 |
WO2017031173A1 (en) * | 2015-08-18 | 2017-02-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Viologen-functionalized porphyrins for reducing biofouling on surfaces |
CN105770989B (zh) * | 2016-03-04 | 2018-09-14 | 中日友好医院 | 一种用于个性化制备人工乳房代用品的生物材料及其方法 |
KR102661010B1 (ko) * | 2016-03-11 | 2024-04-26 | 어쏘시에이션 포 더 어드벤스먼트 오브 티슈 엔지니어링 앤드 셀 베이스드 테크놀로지스 & 테라피즈 (에이4테크)-어쏘시아상 | 생분해성 요관 스텐트, 방법 및 이의 용도 |
CA3020238A1 (en) * | 2016-05-16 | 2017-11-23 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
CN105833354A (zh) * | 2016-05-19 | 2016-08-10 | 中国人民解放军总医院 | 表皮片及其制备方法和应用 |
KR101686988B1 (ko) * | 2016-09-13 | 2016-12-16 | (주) 더아이엔지메디칼 | 복합 수지가 피막 처리된 인체 내강 확장용 스텐트 |
CN106822117B (zh) * | 2016-12-21 | 2019-09-17 | 陈绍良 | 小檗碱的医药用途 |
EP3366322B1 (en) * | 2017-02-22 | 2021-04-28 | Cook Medical Technologies LLC | Medical device with radiopaque metal particles dispersed in polymer |
CN107308501A (zh) * | 2017-07-20 | 2017-11-03 | 南开大学 | 一种在疏水支架材料上负载生物活性蛋白的方法及其用途 |
CN108178962B (zh) * | 2017-12-29 | 2020-06-12 | 华东理工大学 | 一种两性离子防污涂料树脂及其制备方法 |
CN108720971A (zh) * | 2018-01-28 | 2018-11-02 | 杭州市第人民医院 | 一种可控抗菌气管支架 |
CN108676769B (zh) * | 2018-04-24 | 2022-09-23 | 武汉仝干医疗科技股份有限公司 | 一种促进肝细胞生长的无纺布支架材料及其制备方法 |
CN109223253A (zh) * | 2018-08-16 | 2019-01-18 | 河南科技大学第附属医院 | 一种乳房假体 |
CN108939175A (zh) * | 2018-10-24 | 2018-12-07 | 上海市第六人民医院 | 秋水仙碱涂层洗脱支架及其制备方法 |
CN109694570B (zh) * | 2018-12-25 | 2021-08-31 | 江苏利德尔新材料科技有限公司 | 一种高强度超耐磨mc尼龙复合材料及其制备方法 |
US11931482B2 (en) | 2019-03-18 | 2024-03-19 | Brown University | Auranofin-releasing antibacterial and antibiofilm polyurethane intravascular catheter coatings |
CN110124112B (zh) * | 2019-04-02 | 2021-11-23 | 华南理工大学 | 一种基于埃洛石和精氨酸改性聚酯脲氨酯复合材料及其制备与应用 |
RU2740132C9 (ru) * | 2019-04-28 | 2021-04-01 | Евгений Геннадьевич Объедков | Способ нанесения коллагеностимулирующего покрытия на эндопротез |
CN110283296B (zh) * | 2019-06-20 | 2020-07-31 | 中国科学院长春应用化学研究所 | 双功能聚氨酯及其制备方法与应用 |
RU2737505C1 (ru) * | 2019-12-19 | 2020-12-01 | Федеральное государственное бюджетное учреждение науки Институт металлургии и материаловедения им. А.А. Байкова Российской академии наук (ИМЕТ РАН) | Медицинское изделие стент с полимерными покрытиями |
JP2021122748A (ja) * | 2020-02-07 | 2021-08-30 | マイセル・テクノロジーズ,インコーポレイテッド | 生分解性層を有するステント |
CN111714260B (zh) * | 2020-07-17 | 2024-05-17 | 上海浦瑞通医疗科技有限公司 | 一种支架及其应用 |
WO2023055706A1 (en) * | 2021-09-28 | 2023-04-06 | Toray Industries, Inc. | Stent and method for securing air flow by relieving stenosis of respiratory organ |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02246979A (ja) * | 1989-03-22 | 1990-10-02 | Tokyo Baiteku Kenkyusho:Kk | 血管カテーテルおよびその製造方法 |
ATE247435T1 (de) * | 1992-05-08 | 2003-09-15 | Schneider Usa Inc | Stent für den oesophagus |
US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
CA2250295C (en) * | 1996-03-12 | 2008-12-30 | Pg-Txl Company L.P. | Water soluble paclitaxel prodrugs |
RU2117459C1 (ru) * | 1996-12-23 | 1998-08-20 | Закрытое акционерное общество "Научно-производственный комплекс "Экофлон" | Имплантируемый полый протез |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US6206916B1 (en) * | 1998-04-15 | 2001-03-27 | Joseph G. Furst | Coated intraluminal graft |
ATE466603T1 (de) * | 1998-04-27 | 2010-05-15 | Surmodics Inc | Bioaktive wirkstoffe freisetzende beschichtungen |
US6419692B1 (en) * | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6939377B2 (en) * | 2000-08-23 | 2005-09-06 | Thoratec Corporation | Coated vascular grafts and methods of use |
US20020065551A1 (en) * | 2000-09-22 | 2002-05-30 | Koole Levinas H. | Method for immobilizing poly(HEMA) on stents |
WO2002041931A2 (en) * | 2000-11-27 | 2002-05-30 | Medtronic, Inc. | Stents and methods for preparing stents |
US7771468B2 (en) * | 2001-03-16 | 2010-08-10 | Angiotech Biocoatings Corp. | Medicated stent having multi-layer polymer coating |
US6547813B2 (en) * | 2001-03-23 | 2003-04-15 | Medtronic Ave, Inc. | Stent delivery catheter with folded sleeve and method of making same |
US6712845B2 (en) * | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6660034B1 (en) * | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
US6753071B1 (en) * | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
DE10237572A1 (de) * | 2002-08-13 | 2004-02-26 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Stent mit polymerer Beschichtung |
CA2500067A1 (en) * | 2002-09-26 | 2004-04-08 | Endovascular Devices, Inc. | Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
US6702850B1 (en) * | 2002-09-30 | 2004-03-09 | Mediplex Corporation Korea | Multi-coated drug-eluting stent for antithrombosis and antirestenosis |
US7637942B2 (en) * | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
EA011822B1 (ru) * | 2003-09-29 | 2009-06-30 | Хемотек Аг | Медицинский продукт, покрытый биологически стабильным полисульфоновым слоем, и способ нанесения покрытия |
-
2005
- 2005-05-03 KR KR1020077026769A patent/KR20080008364A/ko active Application Filing
- 2005-05-05 DE DE102005021622.6A patent/DE102005021622B4/de not_active Expired - Fee Related
-
2006
- 2006-05-03 US US11/913,545 patent/US8916227B2/en not_active Expired - Fee Related
- 2006-05-03 KR KR1020107005262A patent/KR101084902B1/ko active IP Right Grant
- 2006-05-03 CA CA2607413A patent/CA2607413C/en not_active Expired - Fee Related
- 2006-05-03 ZA ZA200709295A patent/ZA200709295B/xx unknown
- 2006-05-03 JP JP2008509301A patent/JP4758474B2/ja not_active Expired - Fee Related
- 2006-05-03 BR BRPI0610479A patent/BRPI0610479B1/pt not_active IP Right Cessation
- 2006-05-03 WO PCT/DE2006/000766 patent/WO2006116989A2/de active Application Filing
- 2006-05-03 EP EP06742306.1A patent/EP1881853B1/de not_active Not-in-force
- 2006-05-03 MX MX2007013740A patent/MX2007013740A/es active IP Right Grant
- 2006-05-03 ES ES06742306.1T patent/ES2608855T3/es active Active
- 2006-05-03 CN CN2006800152027A patent/CN101171042B/zh not_active Expired - Fee Related
- 2006-05-03 PL PL06742306T patent/PL1881853T3/pl unknown
- 2006-05-03 RU RU2007144939/15A patent/RU2458708C2/ru not_active IP Right Cessation
- 2006-05-03 AU AU2006243553A patent/AU2006243553B2/en not_active Ceased
-
2007
- 2007-10-25 IL IL186917A patent/IL186917A/en not_active IP Right Cessation
-
2008
- 2008-10-02 HK HK08111027.6A patent/HK1119092A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0610479A2 (pt) | 2012-10-30 |
CA2607413C (en) | 2012-06-19 |
US8916227B2 (en) | 2014-12-23 |
WO2006116989A3 (de) | 2007-10-11 |
KR20100035718A (ko) | 2010-04-06 |
RU2007144939A (ru) | 2009-09-10 |
IL186917A0 (en) | 2008-02-09 |
WO2006116989A2 (de) | 2006-11-09 |
PL1881853T3 (pl) | 2017-04-28 |
JP4758474B2 (ja) | 2011-08-31 |
HK1119092A1 (en) | 2009-02-27 |
MX2007013740A (es) | 2008-03-18 |
JP2008539832A (ja) | 2008-11-20 |
CA2607413A1 (en) | 2006-11-09 |
BRPI0610479B1 (pt) | 2018-11-13 |
ZA200709295B (en) | 2009-01-28 |
DE102005021622B4 (de) | 2014-11-20 |
KR20080008364A (ko) | 2008-01-23 |
KR101084902B1 (ko) | 2011-11-17 |
US20080199506A1 (en) | 2008-08-21 |
DE102005021622A1 (de) | 2006-11-16 |
EP1881853A2 (de) | 2008-01-30 |
IL186917A (en) | 2012-07-31 |
CN101171042B (zh) | 2012-01-18 |
RU2458708C2 (ru) | 2012-08-20 |
CN101171042A (zh) | 2008-04-30 |
EP1881853B1 (de) | 2016-09-28 |
AU2006243553B2 (en) | 2010-05-27 |
AU2006243553A1 (en) | 2006-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2608855T3 (es) | Recubrimiento de endoprótesis cubriendo la totalidad de la superficie | |
CA2462723A1 (en) | Coated stents for preventing restenosis | |
US9770576B2 (en) | Methods and apparatuses for coating balloon catheters | |
CA2540382A1 (en) | Biocompatible, biostable coating of medical surfaces | |
CA2558141A1 (en) | Biocompatible coating, method and use of medical surfaces | |
US11167065B2 (en) | Shellac and paclitaxel coated catheter balloons | |
ES2557170T3 (es) | Soporte vascular biodegradable | |
RU2009135014A (ru) | Покрытая расширяемая система | |
US20100010621A1 (en) | Stent having biodegradable stent struts and drug depots | |
RU2008110324A (ru) | Фармацевтическая композиция для профилактики и/или лечения раковых заболеваний, для увеличения активности противораковых лекарств и снижения побочных эффектов противораковых лекарств | |
JP2005506146A5 (es) | ||
RU2012157314A (ru) | Нанесения на эндопротез покрытия, состоящего из плотной сети полимерных волокон | |
CA2484269A1 (en) | Compounds and method for coating surfaces in a haemocompatible manner | |
EP4233927A2 (en) | Drug coated balloon catheters for nonvascular strictures | |
JP2005534724A5 (es) | ||
AU2010306251A1 (en) | Use of compositions to coat catheter balloons and coated catheter balloons | |
US20230372593A1 (en) | Drug coated balloon catheters for nonvascular strictures | |
US20140107574A1 (en) | Catheter balloon coated with rapamycin and shellac | |
DE202012006700U1 (de) | Beschichtung | |
MXPA06003889A (es) | Oligopeptidos como material de revestimiento para productos medicos. | |
WO2012028310A2 (en) | Pharmaceutical compositions comprising a taxane | |
US20130345296A1 (en) | Compositions Comprising a Taxane for Coating Medical Devices | |
EP2729196A1 (en) | Balloon surface coating | |
DE202011002713U1 (de) | Biologisch abbaubare medizinische Beschichtung und deren Verwendung | |
DE202011002929U1 (de) | Stent zur Implantation in den menschlichen Körper |